Fosaprepitant dimeglumine and X-ray abnormal - a phase IV clinical study of FDA data

Summary:

X-ray abnormal is reported as a side effect among people who take Fosaprepitant dimeglumine (fosaprepitant dimeglumine), especially for people who are female, 40-49 old, also take Simponi, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have X-ray abnormal when taking Fosaprepitant dimeglumine. It is created by eHealthMe based on reports of 1,528 people who have side effects when taking Fosaprepitant dimeglumine from the FDA, and is updated regularly.

What is Fosaprepitant dimeglumine?

Fosaprepitant dimeglumine has active ingredients of fosaprepitant dimeglumine. eHealthMe is studying from 1,528 Fosaprepitant dimeglumine users. Check the latest studies of Fosaprepitant dimeglumine.

What is X-ray abnormal?

X-ray abnormal is found to be associated with 360 drugs and 486 conditions by eHealthMe. Check the latest studies of X-ray abnormal.

On Jul, 20, 2026

1,528 people reported to have side effects when taking Fosaprepitant dimeglumine.
Among them, 12 people (0.79%) have X-ray abnormal.

Could Fosaprepitant dimeglumine cause X-ray abnormal?

Among these 12 people:

What is the gender of people who have X-ray abnormal when taking Fosaprepitant dimeglumine? *

female: 100 %
male: 0.0 %

What is the age of people who have X-ray abnormal when taking Fosaprepitant dimeglumine? *

What are other drugs people take besides Fosaprepitant dimeglumine? *

What are other side effects people have besides X-ray abnormal? *

Wound Infection: 12 people, 100.00%
Folliculitis (infection of hair root): 12 people, 100.00%
General Physical Health Deterioration (weak health status): 12 people, 100.00%
Glossodynia (a burning or painful sensation in the tongue): 12 people, 100.00%
Grip Strength Decreased: 12 people, 100.00%
Hair Loss: 12 people, 100.00%
Hand Deformity: 12 people, 100.00%
Head Injury: 12 people, 100.00%
Headache (pain in head): 12 people, 100.00%
Helicobacter Infection (helicobacter pylori (h. pylori) infects stomach): 12 people, 100.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 12 people, 100.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 50.00%
Psoriasis (immune-mediated disease that affects the skin): 5 people, 41.67%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 41.67%
Joint Pain: 3 people, 25.00%
Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 16.67%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 8.33%
Sinusitis (inflammation of sinus): 1 person, 8.33%
Headache (pain in head): 1 person, 8.33%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Fosaprepitant dimeglumine and have X-ray abnormal?

- Check whether X-ray abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fosaprepitant dimeglumine:

Fosaprepitant dimeglumine (1,528 reports)

X-ray abnormal treatments and more:

X-ray abnormal (1,728 reports)

Browse all side effects of Fosaprepitant dimeglumine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with X-ray abnormal:

X-ray abnormal (360 drugs)

Browse all the conditions that are associated with X-ray abnormal:

X-ray abnormal (486 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fosaprepitant dimeglumine (the active ingredients of Fosaprepitant dimeglumine) and Fosaprepitant dimeglumine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.